Biography and Research Information
OverviewAI-generated summary
Ashton Ingold's research examines the impact of non-pharmaceutical interventions during the COVID-19 pandemic on pediatric respiratory infections in Arkansas. Ingold has investigated how these interventions, such as masking and social distancing, were associated with reduced pediatric infections from *Mycoplasma pneumoniae* and other co-infecting respiratory viruses. A focus of this work has been the disproportionate impact on younger and rural children, who were found to be more likely to be hospitalized for SARS-CoV-2 infections.
Further research has explored the effects of these interventions on pediatric asthma exacerbations and viral infections, including shifts in the severity of viral infection in children with asthma. Ingold also contributes to genomic surveillance efforts for SARS-CoV-2, utilizing long-range PCR primers. Collaborations include work with Joshua L. Kennedy, Bobby L. Boyanton Jr, Dana Frederick, and David W. Ussery at the University of Arkansas for Medical Sciences.
Metrics
- h-index: 3
- Publications: 12
- Citations: 35
Selected Publications
-
Hospitalizations and Severity of Rhinovirus-Associated Asthma Exacerbations in Children During the Institution of Non-pharmaceutical Interventions (2026)
-
Resurgence of Respiratory Syncytial Virus Following COVID-19 Pandemic Measures: A Study of Antibody Dynamics in Young Children (2025)
Collaboration Network
Top Collaborators
- SARS-CoV-2 pandemic non-pharmacologic interventions temporally associated with reduced pediatric infections due to <i>Mycoplasma pneumoniae</i> and co-infecting respiratory viruses in Arkansas
- Genomic surveillance of SARS-CoV-2 using long-range PCR primers
- Effects of nonpharmaceutical interventions during COVID-19 pandemic on pediatric asthma exacerbations and viral infections
- Younger and rural children are more likely to be hospitalized for SARS-CoV-2 infections
- Genomic Surveillance of SARS-CoV-2 Using Long-Range PCR Primers
Showing 5 of 11 shared publications
- SARS-CoV-2 pandemic non-pharmacologic interventions temporally associated with reduced pediatric infections due to <i>Mycoplasma pneumoniae</i> and co-infecting respiratory viruses in Arkansas
- Effects of nonpharmaceutical interventions during COVID-19 pandemic on pediatric asthma exacerbations and viral infections
- Severe Acute Respiratory Syndrome Coronavirus-2 Lambda Variant Collected from a Child from Arkansas and Sequenced
- SARS-CoV-2 Pandemic Non-Pharmacologic Interventions Temporally Associated with Reduced Pediatric Infections Due to <i>Mycoplasma pneumoniae</i> and Co-Infecting Respiratory Viruses in Arkansas
- Resurgence of Respiratory Syncytial Virus Following COVID-19 Pandemic Measures: A Study of Antibody Dynamics in Young Children
Showing 5 of 7 shared publications
- Effects of nonpharmaceutical interventions during COVID-19 pandemic on pediatric asthma exacerbations and viral infections
- Younger and rural children are more likely to be hospitalized for SARS-CoV-2 infections
- Younger and Rural Children are More Likely to be Hospitalized for SARS-CoV-2 Infections
- Resurgence of Respiratory Syncytial Virus Following COVID-19 Pandemic Measures: A Study of Antibody Dynamics in Young Children
- From lockdown to recovery: changing patterns of viral infection severity in a pediatric cohort with asthma
Showing 5 of 7 shared publications
- Effects of nonpharmaceutical interventions during COVID-19 pandemic on pediatric asthma exacerbations and viral infections
- Younger and rural children are more likely to be hospitalized for SARS-CoV-2 infections
- Younger and Rural Children are More Likely to be Hospitalized for SARS-CoV-2 Infections
- Resurgence of Respiratory Syncytial Virus Following COVID-19 Pandemic Measures: A Study of Antibody Dynamics in Young Children
- From lockdown to recovery: changing patterns of viral infection severity in a pediatric cohort with asthma
Showing 5 of 6 shared publications
- SARS-CoV-2 pandemic non-pharmacologic interventions temporally associated with reduced pediatric infections due to <i>Mycoplasma pneumoniae</i> and co-infecting respiratory viruses in Arkansas
- Effects of nonpharmaceutical interventions during COVID-19 pandemic on pediatric asthma exacerbations and viral infections
- Severe Acute Respiratory Syndrome Coronavirus-2 Lambda Variant Collected from a Child from Arkansas and Sequenced
- SARS-CoV-2 Pandemic Non-Pharmacologic Interventions Temporally Associated with Reduced Pediatric Infections Due to <i>Mycoplasma pneumoniae</i> and Co-Infecting Respiratory Viruses in Arkansas
- From lockdown to recovery: changing patterns of viral infection severity in a pediatric cohort with asthma
- Genomic surveillance of SARS-CoV-2 using long-range PCR primers
- Genomic Surveillance of SARS-CoV-2 Using Long-Range PCR Primers
- Severe Acute Respiratory Syndrome Coronavirus-2 Lambda Variant Collected from a Child from Arkansas and Sequenced
- Genomic surveillance of SARS-CoV-2 using long-range PCR primers
- Genomic Surveillance of SARS-CoV-2 Using Long-Range PCR Primers
- Severe Acute Respiratory Syndrome Coronavirus-2 Lambda Variant Collected from a Child from Arkansas and Sequenced
- Younger and rural children are more likely to be hospitalized for SARS-CoV-2 infections
- Severe Acute Respiratory Syndrome Coronavirus-2 Lambda Variant Collected from a Child from Arkansas and Sequenced
- Younger and Rural Children are More Likely to be Hospitalized for SARS-CoV-2 Infections
- Effects of nonpharmaceutical interventions during COVID-19 pandemic on pediatric asthma exacerbations and viral infections
- Younger and rural children are more likely to be hospitalized for SARS-CoV-2 infections
- Younger and Rural Children are More Likely to be Hospitalized for SARS-CoV-2 Infections
- Effects of nonpharmaceutical interventions during COVID-19 pandemic on pediatric asthma exacerbations and viral infections
- From lockdown to recovery: changing patterns of viral infection severity in a pediatric cohort with asthma
- Hospitalizations and Severity of Rhinovirus-Associated Asthma Exacerbations in Children During the Institution of Non-pharmaceutical Interventions
- Younger and rural children are more likely to be hospitalized for SARS-CoV-2 infections
- Younger and Rural Children are More Likely to be Hospitalized for SARS-CoV-2 Infections
- Younger and rural children are more likely to be hospitalized for SARS-CoV-2 infections
- Younger and Rural Children are More Likely to be Hospitalized for SARS-CoV-2 Infections
- Younger and rural children are more likely to be hospitalized for SARS-CoV-2 infections
- Younger and Rural Children are More Likely to be Hospitalized for SARS-CoV-2 Infections
- Younger and rural children are more likely to be hospitalized for SARS-CoV-2 infections
- Younger and Rural Children are More Likely to be Hospitalized for SARS-CoV-2 Infections
- Younger and rural children are more likely to be hospitalized for SARS-CoV-2 infections
- Younger and Rural Children are More Likely to be Hospitalized for SARS-CoV-2 Infections
Similar Researchers
Based on overlapping research topics